By the middle of this year, all adults in Britain are due to be offered a Covid-19 vaccine in what is on course to be the fastest inoculation rollout in a major Western country. But disease modelers advising the U.K. government recently made a sobering projection: 56,000 more Covid-19 deaths by the summer of next year, even if the country tiptoes out of lockdown and the vaccines work.
A 10-year-old boy in Michigan has undergone four amputations of his hands and legs after a rare bout of a serious coronavirus-related inflammatory condition.
Johnson & Johnson said Tuesday it can produce 20 million doses of the single-shot coronavirus vaccine by late March and has applied for emergency authorization by the Food and Drug Administration.
Moderna’s president, Dr. Stephen Hoge, plans to tell lawmakers Tuesday that the company received “positive feedback” from the Food and Drug Administration to increase the doses in each vial of vaccine from ten to 15.
A year into the coronavirus pandemic, doctors and researchers are still striving to better understand and treat the accompanying epidemic of COVID-19-related anosmia — loss of smell — draining much of the joy of life from an increasing number of sensorially frustrated longer-term sufferers like Forgione.
Dr. Anthony Fauci, the top disease expert in the U.S., said Monday that Americans who have received their second vaccine jab should still exercise caution and try to resist the urge to dine out or go to the movies.
Americans will likely see life begin to return to normal this summer as coronavirus cases, hospitalizations and deaths continue to decline, former Assistant Secretary for Health Brett Giroir told "The Story" Monday.
The U.S. exceeded a tragic milestone as the nation recorded over half a million lives lost to the novel coronavirus, according to data from Johns Hopkins University.
Amid emerging coronavirus variants, the “direction of the future” will be in developing “potent antivirals” that directly act on the SARS-CoV-2 virus, Dr. Anthony Fauci said on Monday. Fauci, who was partaking in the White House’s COVID-19 briefing, said the nation would need to approach therapeutics similar to the “highly successful drug development program for HIV as well as Hepatitis C.”
COVID-19 survivors who have gotten a first dose of COVID-19 vaccine are generating immune responses that might render a second shot unnecessary, potentially freeing up limited vaccine supply for more people, several new research papers suggest.
GlaxoSmithKline and Sanofi on Monday announced the start of a new Phase 2 trial involving their protein-based COVID-19 vaccine candidate after facing a setback in December.
French drug maker Sanofi, battling development delays with its own vaccine candidates against COVID-19, is turning over more of its vaccine production facilities to industrial competitors, teaming up with Johnson & Johnson to produce millions of doses of its rival coronavirus vaccine.
A Michigan woman contracted COVID-19 and died last fall after she got a double-lung transplant from a donor who turned out to have the virus, according to a study.